Ethanolamine as a potential biomarker and therapeutic target for depressive disorder.

Ogawa S, Hattori K, Hidese S, Sasayama D, Ota M, Miyakawa T, Tatsumi M, Matsumura R, Yoshida S, Noda T, Takebayashi M, Omori W, Itagaki K, Kajitani N, Okada-Tsuchioka M, Hishimoto A, Boku S, Horai T, Monji A, Mizoguchi Y, Tateishi H, Murakawa-Hirachi T, Yoshimura R, Igata R, Kim Y, Hori H, Kunugi H.

Open source

DOI: 10.1038/s41380-026-03559-7
Published: 2026-04-15
Container: Mol Psychiatry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41380-026-03559-7,
  title = {Ethanolamine as a potential biomarker and therapeutic target for depressive disorder.},
  author = {Ogawa S and  Hattori K and  Hidese S and  Sasayama D and  Ota M and  Miyakawa T and  Tatsumi M and  Matsumura R and  Yoshida S and  Noda T and  Takebayashi M and  Omori W and  Itagaki K and  Kajitani N and  Okada-Tsuchioka M and  Hishimoto A and  Boku S and  Horai T and  Monji A and  Mizoguchi Y and  Tateishi H and  Murakawa-Hirachi T and  Yoshimura R and  Igata R and  Kim Y and  Hori H and  Kunugi H.},
  year = {2026},
  journal = {Mol Psychiatry},
  doi = {10.1038/s41380-026-03559-7},
  url = {https://doi.org/10.1038/s41380-026-03559-7}
}

RIS

TY  - JOUR
TI  - Ethanolamine as a potential biomarker and therapeutic target for depressive disorder.
AU  - Ogawa S
AU  -  Hattori K
AU  -  Hidese S
AU  -  Sasayama D
AU  -  Ota M
AU  -  Miyakawa T
AU  -  Tatsumi M
AU  -  Matsumura R
AU  -  Yoshida S
AU  -  Noda T
AU  -  Takebayashi M
AU  -  Omori W
AU  -  Itagaki K
AU  -  Kajitani N
AU  -  Okada-Tsuchioka M
AU  -  Hishimoto A
AU  -  Boku S
AU  -  Horai T
AU  -  Monji A
AU  -  Mizoguchi Y
AU  -  Tateishi H
AU  -  Murakawa-Hirachi T
AU  -  Yoshimura R
AU  -  Igata R
AU  -  Kim Y
AU  -  Hori H
AU  -  Kunugi H.
PY  - 2026
JO  - Mol Psychiatry
DO  - 10.1038/s41380-026-03559-7
UR  - https://doi.org/10.1038/s41380-026-03559-7
ER  -

APA

S, O., K, H., S, H., D, S., M, O., T, M., M, T., R, M., S, Y., T, N., M, T., W, O., K, I., N, K., M, O., A, H., S, B., T, H., A, M., Y, M., H, T., T, M., R, Y., R, I., Y, K., H, H., & H., K. (2026). Ethanolamine as a potential biomarker and therapeutic target for depressive disorder.. Mol Psychiatry. https://doi.org/10.1038/s41380-026-03559-7

Source records

europe-pmc · retrieved 2026-09-26T17:13:20.160Z